ClinicalTrials.govpublic full text
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
colorectal cancer; lung cancer, colorectal cancer, nsclc, pembrolizumab, tirapazamine, liver metastasis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 966140
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.